| dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
| dc.contributor.author | Marthin, June K. |
| dc.contributor.author | Lucas, Jane S |
| dc.contributor.author | Casaulta, Carmen |
| dc.contributor.author | Crowley, Suzanne |
| dc.contributor.author | Destouches, Damien M.S. |
| dc.contributor.author | Moreno Galdó, Antonio |
| dc.contributor.author | Boon, Mieke |
| dc.date.accessioned | 2022-04-08T12:21:41Z |
| dc.date.available | 2022-04-08T12:21:41Z |
| dc.date.issued | 2021-07-01 |
| dc.identifier.citation | Marthin JK, Lucas JS, Boon M, Casaulta C, Crowley S, Destouches DMS, et al. International BEAT-PCD consensus statement for infection prevention and control for primary ciliary dyskinesia in collaboration with ERN-LUNG PCD Core Network and patient representatives. ERJ Open Res. 2021 Jul;7(3):00301–2021. |
| dc.identifier.issn | 2312-0541 |
| dc.identifier.uri | https://hdl.handle.net/11351/7337 |
| dc.description | Primary ciliary dyskinesia; Consensus; Infection prevention |
| dc.description.abstract | Introduction In primary ciliary dyskinesia (PCD) impaired mucociliary clearance leads to recurrent airway infections and progressive lung destruction, and concern over chronic airway infection and patient-to-patient transmission is considerable. So far, there has been no defined consensus on how to control infection across centres caring for patients with PCD. Within the BEAT-PCD network, COST Action and ERS CRC together with the ERN-Lung PCD core a first initiative has now been taken towards creating such a consensus statement.
Methods A multidisciplinary international PCD expert panel was set up to create a consensus statement for infection prevention and control (IP&C) for PCD, covering diagnostic microbiology, infection prevention for specific pathogens considered indicated for treatment and segregation aspects. Using a modified Delphi process, consensus to a statement demanded at least 80% agreement within the PCD expert panel group. Patient organisation representatives were involved throughout the process.
Results We present a consensus statement on 20 IP&C statements for PCD including suggested actions for microbiological identification, indications for treatment of Pseudomonas aeruginosa, Burkholderia cepacia and nontuberculous mycobacteria and suggested segregation aspects aimed to minimise patient-to-patient transmission of infections whether in-hospital, in PCD clinics or wards, or out of hospital at meetings between people with PCD. The statement also includes segregation aspects adapted to the current coronavirus disease 2019 (COVID-19) pandemic.
Conclusion The first ever international consensus statement on IP&C intended specifically for PCD is presented and is targeted at clinicians managing paediatric and adult patients with PCD, microbiologists, patient organisations and not least the patients and their families. |
| dc.language.iso | eng |
| dc.publisher | European Respiratory Society |
| dc.relation.ispartofseries | ERJ Open Research;7(3) |
| dc.rights | Attribution-NonCommercial 4.0 International |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc/4.0/ |
| dc.source | Scientia |
| dc.subject | Malalties cròniques - Prevenció |
| dc.subject | Malalties transmissibles - Transmissió |
| dc.subject | Infeccions respiratòries en els infants |
| dc.subject.mesh | Ciliary Motility Disorders |
| dc.subject.mesh | /prevention & control |
| dc.subject.mesh | Communicable Disease Control |
| dc.subject.mesh | Chronic Disease |
| dc.title | International BEAT-PCD consensus statement for infection prevention and control for primary ciliary dyskinesia in collaboration with ERN-LUNG PCD Core Network and patient representatives |
| dc.type | info:eu-repo/semantics/article |
| dc.identifier.doi | 10.1183/23120541.00301-2021 |
| dc.subject.decs | trastornos de la motilidad ciliar |
| dc.subject.decs | /prevención & control |
| dc.subject.decs | control de enfermedades transmisibles |
| dc.subject.decs | enfermedad crónica |
| dc.relation.publishversion | https://doi.org/10.1183/23120541.00301-2021 |
| dc.type.version | info:eu-repo/semantics/publishedVersion |
| dc.audience | Professionals |
| dc.contributor.organismes | Institut Català de la Salut |
| dc.contributor.authoraffiliation | [Marthin JK] Danish PCD Centre Copenhagen, Paediatric Pulmonary Service, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark. [Lucas JS] Primary Ciliary Dyskinesia Centre, NIHR Respiratory Biomedical Research Centre, Clinical and Experimental Science, University of Southampton, Southampton, UK. [Boon M] Dept of Paediatrics, University Hospital Gasthuisberg, Leuven, Belgium. [Casaulta C] Division of Paediatric Respiratory Medicine, University Children’s Hospital, Bern, Switzerland. [Crowley S] Paediatric Dept of Allergy and Lung Diseases, Oslo University Hospital, Oslo, Norway. [Destouches DMS] Association des Patients Ayant une Dyskinésie Ciliaire Primitive, Limeil-Brevannes, France. [Moreno-Galdó A] Servei de Pediatria, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. CIBER of Rare Diseases (CIBERER), Instituto de Salud Carlos III (ISCIII), Madrid, Spain |
| dc.identifier.pmid | 34350277 |
| dc.identifier.wos | 000684273900037 |
| dc.rights.accessrights | info:eu-repo/semantics/openAccess |